Biocon has tied up with Swiss medical technology company Ypsomed to customise latter's reusable YpsoPen for use with Biocon's insulin cartridges in Malaysia. Biocon has set up one of Asia's largest ...
Ypsomed’s reusable pen compliments Biocon's insulins product portfolio and enables Biocon to further address the growing needs of people with diabetes in Malaysia, the company said. Advisory Alert: It ...
Dublin, Nov. 22, 2024 (GLOBE NEWSWIRE) -- The "Diabetes Injection Pens - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for Diabetes ...
The global diabetes injection pens market is projected to grow at a CAGR of approximately 7% through 2028. Market expansion ...
The Diabetes Injection Pens Market is expected to witness a growth rate of ~7% by 2028. The key factors driving the market are the rising prevalence of diabetes, the growing preference for pens over ...
https://www.thehindubusinessline.com/companies/biocon-mylan-receive-usfda-approval-for-the-launch-of-their-insulin-glargine-injection/article31812447.ece Copy Biocon ...
The "Global Diabetes Injection Pens Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025" report has been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback